nach oben

Acta Diabetologica

Erschienen in:

01.12.2009 | Short Communication

Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis

verfasst von: Rennan Feng, Ying Li, Dan Zhao, Cheng Wang, Yucun Niu, Changhao Sun

Erschienen in: Acta Diabetologica | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

The aim of this meta-analysis was to determine the nature of the association between TNF 238 G/A polymorphism and the risk for T2D. We searched databases updated on January 2009 for all publications on the association between this variation and T2D. Data on genotypes and the numbers of cases and controls were assessed using Review Manager 4.2. Meta-analysis of the overall and specific populations was conducted, and odds ratios (OR) and 95% confidence intervals (95% CI) were calculated in the fixed-effect model. I ² statistic was calculated to examine heterogeneity, and publication bias was evaluated by Egger test. The overall OR (95% CI) for AA and GA genotypes versus GG genotype for TNF-α-238 was 1.15 (0.92–1.44), which in European and Asian populations were 1.18 (0.92–1.51) and 1.13 (0.62–2.04), respectively. This first meta-analysis of data from the current and published studies did not detect any association between the polymorphism of TNF 238 G/A and risk for T2D.

Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91CrossRefPubMed

Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195–3199CrossRefPubMed

Hamaguchi K, Kimura A, Seki N et al (2000) Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 55:10–16CrossRefPubMed

D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150–154PubMed

Fong CL, Siddiqui AH, Mark DF (1994) Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene. Nucleic Acids Res 22:1108–1114CrossRefPubMed

Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M (1998) Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41:430–434CrossRefPubMed

Sheu WH, Lee WJ, Lin LY, Chang RL, Chen YT (2001) Tumor necrosis factor alpha -238 and -308 polymorphisms do not associate with insulin resistance in hypertensive subjects. Metabolism 50:1447–1451CrossRefPubMed

Valenti L, Fracanzani AL, Dongiovanni P et al (2002) Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122:274–280CrossRefPubMed

Hayakawa T, Nagai Y, Taniguchi M et al (2000) Tumor necrosis factor-beta gene NcoI polymorphism decreases insulin resistance in Japanese men. Metabolism 49:1506–1509CrossRefPubMed

10.

Hamann A, Mantzoros C, Vidal-Puig A, Flier JS (1995) Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833–839CrossRefPubMed

11.

Kim HR, Lee MK, Park AJ (2006) [The −308 and −238 polymorphisms of the TNF-alpha promoter gene in type 2 diabetes mellitus]. Korean J Lab Med 26:58–63CrossRefPubMed

12.

Li H, Groop L, Nilsson A, Weng J, Tuomi T (2003) A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2767–2774CrossRefPubMed

13.

Shiau MY, Wu CY, Huang CN, Hu SW, Lin SJ, Chang YH (2003) TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 61:393–397CrossRefPubMed

14.

Santos MJ, Patino GA, Angel BB et al (2006) Association between tumor necrosis factor-alpha promoter polymorphisms and type 2 diabetes and obesity in Chilean elderly women. Rev Med Chil 134:1099–1106

15.

Zeggini E, Groves CJ, Parkinson JR et al (2005) Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes. Diabetologia 48:2013–2017CrossRefPubMed

16.

Chui MH, Papanikolaou Y, Fontaine-Bisson B et al (2007) The TNF-alpha-238G > a single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes. Behav Neurosci 121:619–624CrossRefPubMed

17.

Fontaine-Bisson B, Wolever TM, Chiasson JL et al (2007) Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus. Metabolism 56:649–655CrossRefPubMed

18.

Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63CrossRefPubMed

19.

Aminkeng F, Van Autreve JE, Koeleman BP et al (2007) TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum Immunol 68:690–697CrossRefPubMed

20.

Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF (2000) Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 100:263–269CrossRefPubMed

21.

Molvarec A, Jermendy A, Nagy B et al (2008) Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clin Chim Acta 392:52–57CrossRefPubMed

Titel: Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis
verfasst von: Rennan Feng
Ying Li
Dan Zhao
Cheng Wang
Yucun Niu
Changhao Sun
Publikationsdatum: 01.12.2009
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 4/2009
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-009-0118-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

Diabetes, vascular complications and antiplatelet therapy: open problems

Nateglinide versus repaglinide for type 2 diabetes mellitus in China

Exercise therapy in Type 2 diabetes

Newly detected glucose disturbance is associated with a high prevalence of diastolic dysfunction: double risk for the development of heart failure?

Effects of diabetes and elevated glucose on nitrergic relaxations in the isolated duodenum of the rat

Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria